Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with Diabetes mellitus: A patient-level meta-analysis of randomized trials

Clinical Research in Cardiology

Volumn 100, Issue 7, 2011, Pages 561-570

  De Waha, Antoinette ^a   Dibra, Alban ^a   Kufner, Sebastian ^a   Baumgart, Dietrich ^b   Sabate, Manel ^c   Maresta, Aleardo ^d   Schömig, Albert ^a   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Preventicum Klinik für Diagnostik   (Germany)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

Author keywords

Bare metal stents; Diabetes mellitus; Mortality; Revascularization; Sirolimus eluting stents

Indexed keywords

RAPAMYCIN;

ARTICLE; BARE METAL STENT; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HUMAN; LONG TERM CARE; META ANALYSIS; MORTALITY; PATIENT SAFETY; Q WAVE; REVASCULARIZATION; RISK FACTOR; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 80051800172     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0278-8     Document Type: Article

References (36)

1. Hammoud T, Tanguay JF, Bourassa MG (2000) Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 36(2):355-365 (Pubitemid 30627410)
2. Berry C, Tardif JC, Bourassa MG (2007) Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization. J Am Coll Cardiol 49(6):643-656 (Pubitemid 46205040)
3. Abizaid A, Kornowski R, Mintz GS et al (1998) The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32(3):584-589 (Pubitemid 28435240)
4. Elezi S, Kastrati A, Pache J et al (1998) Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32(7):1866-1873 (Pubitemid 29010448)
5. Weber FD, Schneider H, Wiemer M et al (2008) Sirolimus eluting stent (Cypher TM) in patients with diabetes mellitus: results from the German Cypher Stent Registry. Clin Res Cardiol 97(2):105-109 (Pubitemid 351257994)
6. Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346(23):1773-1780 (Pubitemid 34586912)
7. Moussa I, Leon MB, Baim DS et al (2004) Impact of sirolimuseluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109(19):2273-2278 (Pubitemid 38678518)
8. Abizaid A, Costa MA, Blanchard D et al (2004) Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial. Eur Heart J 25(2):107-112 (Pubitemid 38112148)
9. Hermiller JB, Raizner A, Cannon L et al (2005) Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol 45(8):1172-1179 (Pubitemid 40523133)
10. Briguori C, Colombo A, Airoldi F et al (2005) Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease. Am Heart J 150(4):807-813 (Pubitemid 41396519)
11. Chan C, Zambahari R, Kaul U, Cohen S, Buchbinder M (2007) Outcomes in diabetic patients with multivessel disease and long lesions: results from the DECODE STUDY. http://www.tctmd.com/csportal/appmanager/tctmd/main?-nfpb= true&-pageLabel=TCTMDContent&hdCon=1382193. Accessed 9 Feb 2007
12. Maresta A, Varani E, Balducelli M et al (2008) Comparison of effectiveness and safety of sirolimus-eluting stents versus baremetal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study). Am J Cardiol 101(11):1560-1566
13. Sabate M, Jimenez-Quevedo P, Angiolillo DJ et al (2005) Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 112(14):2175-2183 (Pubitemid 41475813)
14. Jimenez-Quevedo P, Sabate M, Angiolillo DJ et al (2007) Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial. Eur Heart J 28(16):1946-1952 (Pubitemid 47579538)
15. Baumgart D, Klauss V, Baer F et al (2007) One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients. J Am Coll Cardiol 50(17):1627-1634 (Pubitemid 47562680)
16. Egger M, Ebrahim S, Smith GD (2002) Where now for metaanalysis? Int J Epidemiol 31(1):1-5
17. Altman DG, Schulz KF (2001) Statistics notes: concealing treatment allocation in randomised trials. BMJ 323(7310):446-447 (Pubitemid 32801405)
18. Juni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323(7303):42-46 (Pubitemid 32682008)
19. Sterne JAC, Bradburn MJ, Egger M (2001) Meta-analysis in StataTM. In: Egger M, Smith GD, Altman D (eds) Systematic reviews in health care. Blackwell BMJ Books, London, p 357
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557-560 (Pubitemid 37088507)
21. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188 (Pubitemid 17189972)
22. Grundy SM, D'Agostino RB Sr, Mosca L et al (2001) Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop. Circulation 104(4):491-496 (Pubitemid 32678283)
23. Goraya TY, Leibson CL, Palumbo PJ et al (2002) Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 40(5):946-953 (Pubitemid 34994990)
24. Luscher TF, Creager MA, Beckman JA, Cosentino F (2003) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Circulation 108(13):1655-1661 (Pubitemid 37187795)
25. Hurst RT, Lee RW (2003) Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med 139(10):824-834
26. Carrozza JP Jr, Kuntz RE, Fishman RF, Baim DS (1993) Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 118(5):344-349 (Pubitemid 23070618)
27. Kuntz RE (1999) Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma. Circulation 99(7):847-851 (Pubitemid 29094294)
28. Frye RL, Brooks MM, Nesto RW (2003) Gap between clinical trials and clinical practice: lessons from the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 107(14):1837-1839 (Pubitemid 36444120)
29. Stone GW, Ellis SG, Cox DA et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350(3):221-231 (Pubitemid 38067635)
30. Akin I, Bufe A, Schneider S et al (2010) Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry. Clin Res Cardiol 99(6):393-400
31. Tu JV, Bowen J, Chiu M et al (2007) Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 357(14):1393-1402 (Pubitemid 47541971)
32. Marroquin OC, Selzer F, Mulukutla SR et al (2008) A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 358(4):342-352 (Pubitemid 351159233)
33. Iijima R, Byrne RA, Dibra A et al (2009) Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials. Rev Esp Cardiol 62(4):354-364
34. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW (2007) A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356(10):989-997 (Pubitemid 46376799)
35. Kastrati A, Mehilli J, Pache J et al (2007) Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356(10):1030-1039 (Pubitemid 46376803)
36. Kirtane AJ, Ellis SG, Dawkins KD et al (2008) Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol 51(7):708-715 (Pubitemid 351227416)